Stock analysis posts tagged "mergers and acquisitions" from Openbook.

The FTSE 250 record high is a supply signal, not a recovery signal. Mid-cap Britain is being bought and delisted faster than it is being replaced, and the index rises as the market shrinks.

AstraZeneca fell 9% on a reported Bristol Myers Squibb merger approach, Prologis agreed a £14bn deal for SEGRO, and a slide in oil reshaped London's week as the FTSE 250 set back-to-back record closes.